Blog
2 Reasons to Scoop Up Rubrik Stock and Hold on for Life
There are more than two reasons to scoop up Rubrik (NYSE: RBRK) stock and hold onto it for life. Still, the two key points to focus on today are that its Q2 release affirms its robust outlook
Is Coupang the Next MercadoLibre? A Playbook for Global Dominance
Some of the most powerful investment returns come from recognizing a winning business model being replicated in a new global market. For years, investors have watched MercadoLibre (NASDAQ: MELI)
AMD Stock Slipped, But Is It a Breakout Opportunity in Disguise?
Investors following Advanced Micro Devices (NASDAQ: AMD) are navigating a classic market contradiction. AMD’s stock price has seen a notable pullback of over 7% from its recent highs, a move
Chewy’s September Pullback: Is It Your Time to Buy?
Chewy’s (NYSE: CHWY) stock price pulled back unexpectedly following the Q2 earnings release, opening a buying opportunity that should not be ignored.
The company’s results and guidance were
GameStop Returns to Growth, Don’t Expect Another Meme Spike
GameStop (NYSE: GME) is proving the naysayers wrong and returning to growth, but investors and traders should not expect this stock to spike like it has in the past. The company is on track to
AeroVironment Is a Hot Buy With a Double-Digit Upside
AeroVironment (NASDAQ: AVAV) is a hot buy in September due to its business, defense industry position, recent acquisition, and analysts' sentiment trends. The sentiment trends say it all
Why Rate Cuts May Not Put the Fizz Back in Pepsi’s Stock
Even for dividend investors, PepsiCo Inc. (NASDAQ: PEP) shareholders have faced tough times. PEP stock is down 5.89% in 2025 and 19.5% over the last 12 months. But that would be oversimplifying
Nebius Joins the AI Elite After a $17.4 Billion Microsoft Pact
In a market move that captured the attention of the entire technology sector, shares of artificial intelligence (AI) infrastructure provider Nebius Group (NASDAQ: NBIS) delivered a stunning
Amazon’s Chart Forms a Troubling Triple Top: Time for Caution?
Tech giant Amazon.com Inc (NASDAQ: AMZN) closed around the $238 level on Tuesday, leaving it less than $5 shy of February’s all-time high. It’s been a strong couple of weeks for the stock, which
Oil Shorts Are Crowded, 3 Names That Could Bring on a Squeeze
There is a concept on Wall Street called the “pain trade”, part of the trader lingo that signifies an opportunity to bet against the consensus and profit off the pain that most of the crowd could
Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion
On Sept. 8, two market darlings took their rightful place in the world’s most-watched benchmark. Robinhood Markets (NASDAQ: HOOD) and AppLovin (NASDAQ: APP) will join the S&P 500 Index. Both
Despite Pullback, Rocket Lab Still Looks Primed for a Breakout
Despite pulling back close to 12% from its recent 52-week highs, Rocket Lab USA (NASDAQ: RKLB) still looks primed for continuation higher. The stock briefly failed to hold the all-important $50
Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook
Microsoft Corporation (NASDAQ: MSFT) remains a solid performer among technology stocks. MSFT is up more than 18% in 2025, but some investors will find this a little disappointing compared to the
Celsius Stock Surges After Blowout Earnings and Pepsi Deal
The retail sector has been making new headlines recently, especially as it has now outperformed the S&P 500 index by triple digits over the past month alone.
While some point to the Federal
Why Broadcom's Q3 Earnings Were a Huge Win for AVGO Bulls
One of the market’s most anticipated earnings reports was last week, coming from semiconductor giant Broadcom (NASDAQ: AVGO).
Although the company’s financials beat expectations, this alone
Forget QQQ: This ETF Marries the Magnificent 7 and Communications
The technology sector gets a lot of love from financial media, retail investors and sell-side firms. It’s home to the biggest players in the ongoing AI rally, as well as most of the Magnificent
Alphabet Stock’s Weakness Was Wall Street’s Opportunity
Institutional ownership often serves as one of the clearest signals of conviction in a company’s long-term prospects. When the world’s most prominent hedge funds, asset managers, and pension funds
The Utilities Stock at the Center of AI and Rising Electric Bills
Even for Americans living outside of the service areas of giant utilities companies, they’ve earned a reputation for market dominance. NextEra Energy (NYSE: NEE), Southern Company (NYSE: SO), and
Oracle Has Spoken: AI Changes Everything
Anyone surprised by Oracle’s (NYSE: ORCL) Q1 guidance update has not been paying attention to the news stream. Oracle’s forward-looking metrics have been accelerating for over a year as it leans
Beyond DIY: Home Depot's Conquest of the Professional Market
In a strategic campaign of remarkable speed and scale, The Home Depot (NYSE: HD) has committed nearly $24 billion to fundamentally reshaping its business. In early September, the company
3 Plays on Gold in Case Trust in the Fed Slips
With the Trump administration's efforts to exert control over the Federal Reserve, most recently evidenced by the firing of Lisa Cook of the Fed's Board of Governors, the U.S. central bank is
CoreWeave and Madrigal's Insider Trades Flash Bullish Signals
Recent insider trading activity is sending powerful signals to investors—one from a red-hot artificial intelligence (AI) infrastructure company and another from a relatively under-the-radar
August's Most Upgraded: 3 Stocks With +20 Price Target Increases
In August, the S&P 500 Index posted a moderate gain of around 2%, marking its fifth-best monthly performance of 2025. Although August wasn’t a standout month for the general market, it certainly
Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
Shares of Qualcomm Inc. (NASDAQ: QCOM) closed around $160 on Monday, once again running into resistance at a level they have struggled to clear since June.
It is the fourth time in as many
3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
Investing in biotechnology stocks is typically reserved for speculative investors. For starters, many of these companies are clinical or pre-clinical stage companies. They’re not yet profitable

